Olpasiran

Amgen, Cardiovascular, Olpasiran, European Society of Cardiology, small interfering RNA, High Cholesterol

Amgen’s Groundbreaking Discovery: Unleashing the Potential of Olpasiran Beyond Expectations

Anika Sharma

In a revelation that promises to reshape the landscape of cardiovascular health, biotechnology giant Amgen has unveiled extraordinary findings from ...